Concepedia

Author

Shigeru Matsuura

Mitsubishi Tanabe Pharma Corporation

Also Known As

Shigeru Matsuura

5

Publications

192

Citations

4

H-Index

10

Concepts

All Affiliations

Mitsubishi Tanabe Pharma Corporation
SM

About

Shigeru Matsuura is an author at Mitsubishi Tanabe Pharma Corporation specializing in medicine, neuroprotection, and cerebral blood flow.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

69

2

Neurology

2

2

69

3

Pharmacology

2

2

69

4

Brain Injury

2

2

69

5

Cell Death

1

1

45

Shigeru Matsuura

×

4

Publications

192

Citations

4

H-Index

YearCitations

A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia

Akinori Iwashita, Nobuteru Tojo, Shigeru Matsuura,

Journal of Pharmacology and Experimental Therapeutics

2004

82

MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model

Shigeru Matsuura, Yasuhiro Egi, Satoshi Yuki,

Brain Research

2011

45

A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice

Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki,

Journal of Pharmacology and Experimental Therapeutics

2004

41

Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia

Yasuhiro Egi, Shigeru Matsuura, Tomoyuki Maruyama,

Brain Research

2011

24

Page 1